Eric P A Van Dongen Selected Research

Eric P A Van Dongen Research Topics

3	Morbid Obesity 01/2022 - 03/2014
2	Body Weight (Weight, Body) 10/2019 - 03/2014
1	Infections 01/2022
1	Obesity 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Sepsis (Septicemia) 10/2019
1	Postoperative Hemorrhage 01/2019
1	Surgical Wound Infection 03/2014

2	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 03/2014
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	FluoroquinolonesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AminoglycosidesIBA 10/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 10/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	Cefazolin (Ancef)FDA LinkGeneric 03/2014

1	Intravenous Administration 01/2022
1	Therapeutics 01/2022
1	Bariatric Surgery 10/2019